Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA halts testing of Regulus' Hep C drug, sending shares into tailspin
FDA halts testing of Regulus' Hep C drug, sending shares into tailspin
FDA halts testing of Regulus' Hep C drug, sending shares into tailspin
Submitted by
admin
on June 28, 2016 - 11:04am
Source:
BioPharma Dive
News Tags:
FDA
Regulus
hepatitis C
clinical trials
RG-101
Headline:
FDA halts testing of Regulus' Hep C drug, sending shares into tailspin
Do Not Allow Advertisers to Use My Personal information
